Malcolm Farquharson

408 total citations
6 papers, 255 citations indexed

About

Malcolm Farquharson is a scholar working on Molecular Biology, Reproductive Medicine and Oncology. According to data from OpenAlex, Malcolm Farquharson has authored 6 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Reproductive Medicine and 2 papers in Oncology. Recurrent topics in Malcolm Farquharson's work include CRISPR and Genetic Engineering (4 papers), Ovarian cancer diagnosis and treatment (4 papers) and Cancer-related molecular mechanisms research (1 paper). Malcolm Farquharson is often cited by papers focused on CRISPR and Genetic Engineering (4 papers), Ovarian cancer diagnosis and treatment (4 papers) and Cancer-related molecular mechanisms research (1 paper). Malcolm Farquharson collaborates with scholars based in United Kingdom and United States. Malcolm Farquharson's co-authors include Suzanne Dowson, Iain A. McNeish, Josephine Walton, Susan Mason, David Stevenson, Karen Blyth, Darren Ennis, Elaine Leung, Douglas Strathdee and Clare Orange and has published in prestigious journals such as Cancer Research, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Malcolm Farquharson

6 papers receiving 255 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Malcolm Farquharson United Kingdom	3	138	112	88	56	55	6	255
Suzanne Dowson United Kingdom	7	177 1.3×	170 1.5×	100 1.1×	77 1.4×	94 1.7×	11	348
Luisa Manning United States	12	199 1.4×	111 1.0×	117 1.3×	71 1.3×	26 0.5×	28	299
Galaxia M. Rodriguez Canada	8	187 1.4×	125 1.1×	270 3.1×	49 0.9×	30 0.5×	18	395
Phylicia Aaron United States	11	159 1.2×	80 0.7×	104 1.2×	66 1.2×	19 0.3×	20	285
Thijs Roelofsen Netherlands	11	61 0.4×	137 1.2×	92 1.0×	158 2.8×	72 1.3×	12	370
Nayara Gusmão Tessarollo Brazil	8	83 0.6×	120 1.1×	36 0.4×	20 0.4×	17 0.3×	16	241
Kanwaldeep Kaur Rasila United States	5	112 0.8×	239 2.1×	74 0.8×	27 0.5×	30 0.5×	9	345
Hao Ran United States	3	105 0.8×	93 0.8×	41 0.5×	112 2.0×	13 0.2×	4	236
Eri Ichikawa Japan	9	118 0.9×	179 1.6×	233 2.6×	10 0.2×	32 0.6×	12	438

Countries citing papers authored by Malcolm Farquharson

Since Specialization

Citations

This map shows the geographic impact of Malcolm Farquharson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malcolm Farquharson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malcolm Farquharson more than expected).

Fields of papers citing papers by Malcolm Farquharson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malcolm Farquharson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malcolm Farquharson. The network helps show where Malcolm Farquharson may publish in the future.

Co-authorship network of co-authors of Malcolm Farquharson

This figure shows the co-authorship network connecting the top 25 collaborators of Malcolm Farquharson. A scholar is included among the top collaborators of Malcolm Farquharson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malcolm Farquharson. Malcolm Farquharson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Leung, Elaine, Darren Ennis, Philippa R Kennedy, et al.. (2020). NK Cells Augment Oncolytic Adenovirus Cytotoxicity in Ovarian Cancer. Molecular Therapy — Oncolytics. 16. 289–301. 35 indexed citations

2.

Walton, Josephine, Malcolm Farquharson, Susan Mason, et al.. (2018). Abstract PR14: CRISPR/Cas9-mediated Trp53, Brca1, Brca2, Pten, and Nf1 knockout to generate improved murine models of ovarian high-grade serous carcinoma. Clinical Cancer Research. 24(15_Supplement). PR14–PR14. 1 indexed citations

3.

Walton, Josephine, Malcolm Farquharson, Susan Mason, et al.. (2017). CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivity. PMC. 2 indexed citations

4.

Walton, Josephine, Malcolm Farquharson, Susan Mason, et al.. (2017). CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivity. Scientific Reports. 7(1). 16827–16827. 66 indexed citations

5.

Walton, Josephine, Julianna Blagih, Darren Ennis, et al.. (2016). CRISPR/Cas9-Mediated Trp53 and Brca2 Knockout to Generate Improved Murine Models of Ovarian High-Grade Serous Carcinoma. Cancer Research. 76(20). 6118–6129. 150 indexed citations

6.

Farquharson, Malcolm, et al.. (2011). Prognostic factors for survival after neoadjuvant chemotherapy for advanced ovarian cancer: meta-analysis. Open Journal of Obstetrics and Gynecology. 1(3). 71–83. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact